Clinical trial
GSK372475 Bioequivalence Study
NCT00488098 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00488098 |
|---|---|
| Title | GSK372475 Bioequivalence Study |
| Official title | An Open Label, Randomized, Parallel Groups, Bioequivalence Study to Compare a Single Oral Dose of GSK372475B or GSK372475C in Male and Female Healthy Volunteers. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy Subjects, Depressive Disorder |
| Intervention type | Drug |
| Interventions | GSK372475 |
| Enrollment | 66 |
| Start date | Jul 1, 2007 |
| First posted | Jun 19, 2007 |
| Last update posted | Jun 4, 2012 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: